ClassID:

110352

C12N2740/14022 - CPC Classification

Classification description:

Reverse transcribing RNA viruses; Details; Retroviridae; Deltaretrovirus, e.g. bovine leukeamia virus New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Recent Application in this class:
#1
20230019590
2023-01-19

BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING

#2
20220389451
2022-12-08

COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL

#3
20200033342
2020-01-30

Soluble and immunoreactive variants of HTLV capsid antigen P24

#4
20190000963
2019-01-03

Vaccine against bovine leukemia virus

#5
20180305666
2018-10-25

Methods for generating engineered human primary blood dendritic cell lines

#6
20180099042
2018-04-12

Chimeric peptides against HTLV-1

#7
20180002383
2018-01-04

GLUT-1 AS A RECEPTOR FOR HTLV ENVELOPES AND ITS USES

#8
20170184591
2017-06-29

Soluble and immunoreactive variants of HTLV capsid antigen p24

#9
20170039314
2017-02-09

BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING

#10
20160331831
2016-11-17

Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 1

#11
20160045593
2016-02-18

Vaccine against bovine leukemia virus

#12
20150133363
2015-05-14

GLUT-1 as a receptor for HTLV envelopes and its uses

#13
20140080121
2014-03-20

Primate T-lymphotropic viruses

#14
20120090043
2012-04-12

TARGETS FOR RETROVIRUS ASSOCIATED DISEASES

#15
20110275146
2011-11-10

FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS

#16
20110250624
2011-10-13

Method for the production and purification of bovine leukemia virus GP51 surface glycoprotein in the absence of bovine serum

#17
20110150883
2011-06-23

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER

#18
20100317034
2010-12-16

Primate T-lymphotropic viruses

#19
20100291680
2010-11-18

METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION

#20
20100256040
2010-10-07

COMPOSITION AND METHOD FOR TREATING VIRAL INFECTION

#21
20100160420
2010-06-24

Simian T-cell lymphotropic virus

#22
20080311124
2008-12-18

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER

#23
20080311123
2008-12-18

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER

#24
20080292657
2008-11-27

Primate T-lymphotropic viruses

#25
20080219991
2008-09-11

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER

#26
20080219990
2008-09-11

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER

#27
20080219989
2008-09-11

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER

#28
20080219982
2008-09-11

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER

#29
20080206249
2008-08-28

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER

#30
20080206245
2008-08-28

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER

#31
20080206244
2008-08-28

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER

#32
20080206234
2008-08-28

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER

#33
20070202123
2007-08-30

Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier

#34
20070037141
2007-02-15

Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission

#35
20060287513
2006-12-21

Compositions and methods for the therapy and diagnosis of breast cancer

#36
20060153862
2006-07-13

Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses

#37
20060127989
2006-06-15

Antigenic fragment of human T-lymphotropic virus

#38
20060111551
2006-05-25

Peptide having HTLV-1-specific CTL-inducing activity

#39
20060083749
2006-04-20

Compositions and methods for the therapy and diagnosis of breast cancer

#40
20050214945
2005-09-29

Htlv-I tax induced killing of p53 null cancer cells

#41
20050208481
2005-09-22

Diagnostic device using GP40

#42
20050095581
2005-05-05

Detection of HIV-1 DNA